skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Summary

Query: Party Name contains all words: AVENTIS, INC.
Number of results: 69
Results are in reverse chronological order

Page #2. Previous 1 3 Next
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
78658898
04/19/2006
Glaxo Group Limited
Mark: SELTAR S#:78658898
Aventis Pharmaceuticals, Inc.
91169670
03/02/2006
Greystone Medical Group, Inc.
Mark: DERMXL S#:78487108
Aventis Pharmaceuticals Inc.
78430101
03/07/2006
Aventis Pharmaceuticals Inc.
Mark: THE CACTUS CLUB S#:78430101
Sentra Industries, Inc.
91167809
12/01/2005
SEA-QUILL USA, INC
Mark: OSTEO-CAL S#:78552259
AVENTIS HOLDINGS INC.,
78552259
11/09/2005
SEA-QUILL USA, INC
Mark: OSTEO-CAL S#:78552259
Martec Industries, Inc.
AVENTIS HOLDINGS INC.,
78523521
10/28/2005
Schering Aktiengesellschaft
Mark: AZETA S#:78523521
Aventis Pharmaceuticals Inc.
78487108
09/27/2005
Greystone Medical Group, Inc.
Mark: DERMXL S#:78487108
Aventis Pharmaceuticals Inc.
91166636
08/23/2005
STARKE, RICHARD J.
Mark: DIABET ~ RX S#:76593667
AVENTIS HOLDINGS, INC
91165297
05/17/2005
TransForm Pharmaceuticals, Inc.
Mark: DERMAX S#:78308807
Aventis Pharmaceuticals, Inc.
Mark: DERMIK S#:72180077 R#:793936
76593667
05/20/2005
STARKE, RICHARD J.
Mark: DIABET ~ RX S#:76593667
Aventis Holdings, Inc.
FNC MEDICAL CORPORATION
AVENTIS HOLDINGS, INC
91164536
03/14/2005
Large Scale Biology Corporation
Mark: ENZAGAL S#:76562928
AVENTIS PHARMACEUTICALS INC.
Mark: BENZAGEL S#:75302823 R#:2162103
91164217
02/07/2005
Primus Pharmaceuticals, Inc.
Mark: NOVACORT S#:78308205
Aventis Pharmaceuticals Inc. .
Mark: NASACORT S#:73689308 R#:1538836
78308807
02/03/2005
TransForm Pharmaceuticals, Inc.
Mark: DERMAX S#:78308807
Aventis Pharmaceuticals, Inc.
Mark: DERMIK S#:72180077 R#:793936
Aventis Pharmaceuticals Inc.
Novartis AG
Novartis AG
Mark: DERAMAXX S#:78033334 R#:2744806
91163939
01/26/2005
Neurorecovery, Inc.
Mark: GABAMIDE S#:78371821
Aventis Pharmaceuticals Inc.
Mark: VANAMIDE S#:78144180 R#:2803690
91163788
01/03/2005
Schering Aktiengesellschaft
Mark: GAVINAR S#:76506927
Aventis Holdings Inc. and Smithkline Bee
Mark: GAVISCON S#:72235754 R#:828755
91163536
12/21/2004
DEL PHARMACEUTICALS, INC.
Mark: DIABETAID S#:76356223
AVENTIS HOLDINGS INC.
Mark: DIABETA S#:72456845 R#:978443
76562928
09/27/2004
Large Scale Biology Corporation
Mark: ENZAGAL S#:76562928
Aventis Pharmaceuticals Inc.
AVENTIS PHARMACEUTICALS INC.
Mark: BENZAGEL S#:75302823 R#:2162103
76356223
09/09/2004
DEL PHARMACEUTICALS, INC.
Mark: DIABETAID S#:76356223
AVENTIS HOLDINGS, INC.
AVENTIS HOLDINGS INC.
Mark: DIABETA S#:72456845 R#:978443
78308205
08/31/2004
Primus Pharmaceuticals, Inc.
Mark: NOVACORT S#:78308205
Medicis Pharmaceutical Corporation
Aventis Pharmaceuticals Inc.
Aventis Pharmaceuticals Inc. .
Mark: NASACORT S#:73689308 R#:1538836
76506927
07/27/2004
Schering Aktiengesellschaft
Mark: GAVINAR S#:76506927
AVENTIS HOLDINGS, INC.
Aventis Holdings Inc. and Smithkline Beecham Corporation
Mark: GAVISCON S#:72235754 R#:828755
91161410
07/14/2004
Vitaquest International, Inc.
Mark: PHOSACAL S#:78264334
Aventis Holdings, Inc., and SmithKline Beecham Corporation
76524476
06/25/2004
Ledesma, Glenn N.
Mark: DERMA RX S#:76524476
Greystone Medical Group, Inc.
Avon Products, Inc.
AVENTIS PHARMACEUTICALS INC.
GREYSTONE MEDICAL GROUP, INC.
Mark: DERMRX S#:78251358
91160499
05/12/2004
Greystone Medical Group, Inc.
Mark: DERMRX S#:78251358
Aventis Pharmaceuticals Inc.
Mark: DERMIK S#:72180077 R#:793936
78264334
03/16/2004
Vitaquest International, Inc.
Mark: PHOSACAL S#:78264334
Aventis Holdings, Inc., and SmithKline Beecham Corporation
AVENTIS HOLDINGS INC.
78251358
02/04/2004
Greystone Medical Group, Inc.
Mark: DERMRX S#:78251358
Aventis Pharmaceuticals Inc.
Mark: DERMIK S#:72180077 R#:793936
Page #2. Previous 1 3 Next

Results as of 04/26/2024 03:32 PMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY